BOSTON (CBS) — The Dana Farber Cancer Institute and Boston Children’s Hospital will operate to fight cancer at a new way due to some other treatment approved by the FDA.
CAR-T treatment is for kids and young adults with relapsed and refractory acute lymphoblastic leukemia (ALL).
“It is actually an entirely new type of treatment, a totally new way to fight cancer,” said Dr. Lewis Silverman, the Clinical Director of the Pediatric Hematologic Malignancies Center.
Chemotherapy drugs attack dividing cells but are not specific to cancer cells according to Silverman.
“It is a pretty exciting new treatment that involves taking a patient’s own white blood cell called a T mobile and redirecting it by genetically engineering it outside the body. So it is going to attack the cancer cell, in this case, a youth leukemia cell,” explained Silverman.
Mitchell Carson (Courtesy Photo)
Mitchell Carson battled leukemia for many years it spread to his mind.
“Three decades of fighting, all of the sacrifices I had made, it just seemed like it was all wasted,” he said.
Therapy changed that.
Michelle Denault (WBZ-TV)
The Michelle Denault, that had been battling lymphoma of Groveland, also benefited from the new medication.
“It was devastating when they told me nothing could be achieved,” Denault remembered.
She had been once given to live but is now almost a year and a half to remission.
“My immune system just awakened and went into action. It could. It was a game changer,” she said.
There are cases of ALL per year.
The medication was only qualified for childhood leukemia but consent could be next.